Instrument Business Outlook Volume 33 - Issue 1

17 Apr 2024

Categories:

Instrument Business Outlook

Table of Contents

The Top 30 Companies of 2023
- Top Companies Dominate
- Changes to the List
- Life Science’s Presence
- Geographic Diversity
Executive Briefing
- Bruker to Acquire NanoString
- EU and Illumina Reach Agreement
- PacBio Cuts Quarterly and Annual Forecasts
- Icahn-Endorsed Director to Leave Illumina Board
- NanoString Delists
- Skalar Buys EST
- Battery Further Invests in Lab Informatics
Fourth Quarter Results: 10x Genomics, HORIBA, Oxford Nanopore, Pacific Biosciences and Tecan
- 10x Genomics’ 2024 Sales Boosted by Spatial Franchise
  - Q4
  - FYE
- HORIBA’s Water Quality Systems See Strength in the Americas and Asia
  - Q4
  - FYE
- Oxford Nanopore Sees Strength Outside of COVID-19 Market
  - Life Science Research Tools Division
  - Geography
  - Guidance
- Pacific Biosciences Concludes 2023 on a High Note
  - Q4
  - FYE
- Tecan Produced Mixed Regional Sales Results
  - H2
  - FYE
Market Profile: Portable MS
- Leading Vendors
- Largest Markets
- Instrument Cost
Industry Watch
- Government & Environment: PFAS Limits Finalized
- Biopharma: Cell and Gene Therapy Q1 Update
- Government and R&D: Latest NSF Statistics
Region Watch
- China: Companies Respond to the Biosecure Act
- India: FDA Crackdown
- Brazil: Stalemate Stalls Science Funding
News
- MS, LC/MS & GC/MS
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- Chromatography
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- Informatics
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- Materials Characterization
  - Company Announcements
  - Product Introductions
Bottom Line

Attachments

IBO 041724 Issue.pdf